ReviewBiomolecules2022

SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease.

Giulia Gorrieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.